Cross-resistance to ON01910.Na among drug-resistant human tumor cell lines
Adrian Preda(University of California, Irvine), E. Premkumar Reddy(The Graduate Center, CUNY), Jian‐Dong Jiang(Ningbo University), Takao Ohnuma(Temple University), James F. Holland(Mayo Clinic)
Cancer Research
April 15, 2006
Cited by 3
Related Papers
Drugging the 'undruggable' cancer targets
|Nature reviews. Cancer|2017|912
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Filtration Leukapheresis for Granulocyte Transfusion Therapy
|New England Journal of Medicine|1975|255